Results 231 to 240 of about 82,056 (278)

Pharmacotherapy Risks in Rare Genetic Diseases: Cross-Referencing ACMG Secondary Findings v3.2 List With Clinical Databases. [PDF]

Clin Transl Sci
Allen JD, Duong BQ, Brady J, Arn P.
europepmc   +1 more source

Clinical significance, prognosis, and risk model of SDHB expression loss and ERBB2 expression in pheochromocytoma and paraganglioma. [PDF]

Endocr Connect
Zhang S, Yang Y, Li W, Shi S.
europepmc   +1 more source

ACTH-producing pituitary adenomas in Cushing´s disease [PDF]

, 1980
Fahlbusch, R., Müller, O. A., Scriba, Peter Christian, Stass, P.   +3 more
core  

Correction: Case series: <i>ATRX</i> variants in four patients with metastatic pheochromocytoma. [PDF]

Front Endocrinol (Lausanne)
Cortez BN, Kuo MJM, Jha A, Patel M, Carrasquillo JA, Prodanov T, Charles KM, Talvacchio S, Derkyi A, Lin FI, Taïeb D, Del Rivero J, Pacak K.   +12 more
europepmc   +1 more source

Case report: Von Hippel-Lindau syndrome with multisystem involvement: a therapeutic dilemma. [PDF]

Front Oncol
He S, Wang C, Yang J, Shen J, Zeng X, Zheng J, Wang Y.   +6 more
europepmc   +1 more source

Diagnostic and prognostic utility of insulinoma-associated protein 1, insulin gene enhancer protein 1, and secretagogin in pheochromocytoma. [PDF]

Rev Assoc Med Bras (1992)
Sözen M, Turan G, Cantürk Z, Çetinarslan B, Selek A, Tosun M, Civriz AH, Sevinç B, Gezer E, Köksalan D.   +9 more
europepmc   +1 more source

Incidental Adrenal Mass in a Patient With a Known History of Neurofibromatosis: A Case Report. [PDF]

Cureus
Jacobsen TP, Keles GB, Amer SS, Mogilevskiy V, Patel KT.   +4 more
europepmc   +1 more source